Beste The Lancet Diabetes Podcasts (2024)

Professor Roy Taylor joins Lauren Southwell to talk about his Review discussing the causes of type 2 diabetes. Read the full article: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(24)00157-8?dgcid=buzzsprout_icw_podcast_generic_landia Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https:/…

1
In conversation with... Ponnusamy Saravanan, Uma Ram, and Kosgei Wycliffe 33:42

Play Pause

5M ago33:42

33:42

Professor Ponnusamy Saravanan, Dr Uma Ram, and Dr Kosgei Wycliffe join Lauren Southwell to discuss STRiDE, a prospective cohort study in India and Kenya, and the multi-ethnic PRiDE cohort in the UK to assess early pregnancy HbA1c as a screening test for gestational diabetes.Von The Lancet

1
Ponnusamy Saravanan, Uma Ram, and Kosgei Wycliffe on early pregnancy HbA1c as a screening test for gestational diabetes 33:42

5M ago33:42

33:42

Professor Ponnusamy Saravanan, Dr Uma Ram, and Dr Kosgei Wycliffe join Lauren Southwell to discuss STRiDE, a prospective cohort study in India and Kenya, and the multi-ethnic PRiDE cohort in the UK to assess early pregnancy HbA1c as a screening test for gestational diabetes. Read the full article: https://www.thelancet.com/journals/landia/article/P…

1
Márta Korbonits on mechanisms of ageing 13:27

2y ago13:27

13:27

Márta Korbonits talks with The Lancet Diabetes & Endocrinology about mechanisms of ageing: growth hormone, dietary restriction, and metformin. Read the full article: Mechanisms of ageing: growth hormone, dietary restriction, and metformin Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com…

1
In conversation with... Márta Korbonits 13:27

2y ago13:27

13:27

Márta Korbonits talks with The Lancet Diabetes & Endocrinology about mechanisms of ageing: growth hormone, dietary restriction, and metformin.Von The Lancet

1
Mirjam Christ-Crain and Cihan Atila on the patient's perspective of central diabetes insipidus 8:17

2y ago8:17

8:17

Mirjam Christ-Crain and Cihan Atila talk with The Lancet Diabetes & Endocrinology about central diabetes insipidus from a patient's perspective. Read the full article: Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey Conti…

1
In conversation with... Mirjam Christ-Crain and Cihan Atila 8:17

2y ago8:17

8:17

Mirjam Christ-Crain and Cihan Atila talk with The Lancet Diabetes & Endocrinology about central diabetes insipidus from a patient's perspective.Von The Lancet

1
Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma 9:42

2+ y ago9:42

9:42

Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma. Read the full article: Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma Continue this conversation on social! Follow us today at... https://twi…

1
In conversation with... Niki Karavitaki 9:42

2+ y ago9:42

9:42

Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma.Von The Lancet

1
In conversation with... Rossella Nappi 17:28

2+ y ago17:28

17:28

Rossella Nappi talks with The Lancet Diabetes & Endocrinology about cardiometabolic changes that occur during the menopausal transition and implications for women’s health.Von The Lancet

1
Rossella Nappi on menopause as a turning point for women's health 17:28

2+ y ago17:28

17:28

Rossella Nappi talks with The Lancet Diabetes & Endocrinology about cardiometabolic changes that occur during the menopausal transition and implications for women’s health. Read the full Series: Menopause Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.c…

1
Louise Baur on the causes of child and adolescent obesity 11:26

2+ y ago11:26

11:26

Louise Baur talks with The Lancet Diabetes & Endocrinology about the prevalence and causes of child and adolescent obesity, and the need for personalised treatment approaches. Read the full article: Obesity in children and adolescents: epidemiology, causes, assessment, and management Continue this conversation on social! Follow us today at... https…

1
In conversation with... Louise Baur 11:26

2+ y ago11:26

11:26

Louise Baur talks with The Lancet Diabetes & Endocrinology about the prevalence and causes of child and adolescent obesity, and the need for personalised treatment approaches.Von The Lancet

1
Margherita Pizzato on the global epidemiological landscape of thyroid cancer 19:36

2+ y ago19:36

19:36

Margherita Pizzato talks with The Lancet Diabetes & Endocrinology about the global epidemiological landscape of thyroid cancer based on GLOBOCAN estimates in 2020. Read the full article: The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020 Continue this conversation on social! Follo…

1
In conversation with...Margherita Pizzato 19:36

2+ y ago19:36

19:36

Margherita Pizzato talks with The Lancet Diabetes & Endocrinology about the global epidemiological landscape of thyroid cancer based on GLOBOCAN estimates in 2020.Von The Lancet

1
In conversation with... Angela Titmuss 11:44

3y ago11:44

11:44

Angela Titmuss talks with The Lancet Diabetes & Endocrinology about youth-onset type 2 diabetes among First Nations young people in northern Australia.Von The Lancet

1
Angela Titmuss on T2D in First Nations young people in northern Australia 11:44

3y ago11:44

11:44

Angela Titmuss talks with The Lancet Diabetes & Endocrinology about youth-onset type 2 diabetes among First Nations young people in northern Australia. Read the full article: Youth-onset type 2 diabetes among First Nations young people in northern Australia Continue this conversation on social! Follow us today at... https://twitter.com/thelancet ht…

1
Sanjay Basu on affordable T2D medicine in LMICs 9:42

3y ago9:42

9:42

Sanjay Basu talks with The Lancet Diabetes & Endocrinology about what is an affordable price for newer type 2 diabetes medicines in low-income and middle-incomes countries. Read the full article: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00240-0/fulltext Continue this conversation on social! Follow us today at... https://tw…

1
In conversation with... Sanjay Basu 9:42

3y ago9:42

9:42

Sanjay Basu talks with The Lancet Diabetes & Endocrinology about what is an affordable price for newer type 2 diabetes medicines in low-income and middle-incomes countries.Von The Lancet

1
Philip Home on the centenary of insulin 13:00

3y ago13:00

13:00

Philip Home talks with The Lancet Diabetes & Endocrinology about the insulin centenary and how insulin therapy might develop in the future. Read the full article: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00182-0/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://insta…

1
In conversation with... Philip Home 13:00

3y ago13:00

13:00

Philip Home talks with The Lancet Diabetes & Endocrinology about the insulin centenary and how insulin therapy might develop in the future.Von The Lancet

1
Victoria Salem on improving female inclusion in conferences 11:52

3+ y ago11:52

11:52

Victoria Salem talks with The Lancet Diabetes & Endocrinology about how to improve female inclusion and participation in scientific medical conferences. Read the full article: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00177-7/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet …

1
In conversation with... Victoria Salem 11:52

3+ y ago11:52

11:52

Victoria Salem talks with The Lancet Diabetes & Endocrinology about how to improve female inclusion and participation in scientific medical conferences.Von The Lancet

1
In conversation with... Hertzel Gerstein 24:00

3+ y ago24:00

24:00

Hertzel Gerstein talks with The Lancet Diabetes & Endocrinology about how dulaglutide might reduce the incidence of moderate or severe erectile dysfunction in men with type 2 diabetes.Von The Lancet

1
Hertzel Gerstein on dulaglutide, erectile dysfunction, and T2D 24:00

3+ y ago24:00

24:00

Hertzel Gerstein talks with The Lancet Diabetes & Endocrinology about how dulaglutide might reduce the incidence of moderate or severe erectile dysfunction in men with type 2 diabetes. Read the full article: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00115-7/fulltext Continue this conversation on social! Follow us today at..…

1
In conversation with... Rishi Caleyachetty 5:40

3+ y ago5:40

5:40

Rishi Caleyachetty talks with The Lancet Diabetes & Endocrinology about the need to revise ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk.Von The Lancet

1
Rishi Caleyachetty on ethnicity-specific BMI 5:40

3+ y ago5:40

5:40

Rishi Caleyachetty talks with The Lancet Diabetes & Endocrinology about the need to revise ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk. Read the full article: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00088-7/fulltext Continue this conversation on social! Follow us today at... https://twitter.co…

1
In Conversation With... Thomas Robinson 17:41

3+ y ago17:41

17:41

Thomas Robinson talks with The Lancet Diabetes & Endocrinology about the Stanford GOALS randomised controlled trial in Latinx children with overweight or obesity.Von The Lancet

1
Thomas Robinson on obesity in Latinx children 17:41

3+ y ago17:41

17:41

Thomas Robinson talks with The Lancet Diabetes & Endocrinology about the Stanford GOALS randomised controlled trial in Latinx children with overweight or obesity. Read the full article: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00084-X/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/…

1
In Conversation With... Adrian Martineau 10:26

3+ y ago10:26

10:26

Adrian Martineau talks with The Lancet Diabetes & Endocrinology about how vitamin D supplementation can reduce the risk of acute respiratory infections.Von The Lancet

1
Adrian Martineau on Vitamin D and respiratory infections 10:26

3+ y ago10:26

10:26

Adrian Martineau talks with The Lancet Diabetes & Endocrinology about how vitamin D supplementation can reduce the risk of acute respiratory infections. Read the full article: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00051-6/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet …

1
Calorie restriction and cardiometabolic risk 5:27

5+ y ago5:27

5:27

William Kraus talks with The Lancet Diabetes & Endocrinology about how calorie restriction can reduce cardiometabolic risk even in young, healthy, non-obese adults. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linke…

1
Calorie restriction and cardiometabolic risk 6:07

5+ y ago6:07

6:07

William Kraus talks with The Lancet Diabetes & Endocrinology about how calorie restriction can reduce cardiometabolic risk even in young, healthy, non-obese adults.Von The Lancet

1
Albuminuria and end-stage kidney disease 9:49

6y ago9:49

9:49

Hiddo Lambers Heerspink talks with The Lancet Diabetes & Endocrinology about his work on changes in albuminuria and subsequent effect on kidney disease. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/comp…

1
Albuminuria and end-stage kidney disease 10:13

6y ago10:13

10:13

Hiddo Lambers Heerspink talks with The Lancet Diabetes & Endocrinology about his work on changes in albuminuria and subsequent effect on kidney disease.Von The Lancet

1
Type 1 diabetes and immune-based therapies 17:28

6y ago17:28

17:28

Mark Atkinson and Bart Roep join The Lancet Diabetes & Endocrinology to discuss a new Series on immune-based therapies for type 1 diabetes. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lance…

1
Type 1 diabetes and immune-based therapies 18:00

6y ago18:00

18:00

Mark Atkinson and Bart Roep join The Lancet Diabetes & Endocrinology to discuss a new Series on immune-based therapies for type 1 diabetes.Von The Lancet

1
Ageing and endocrinology 25:07

6+ y ago25:07

25:07

Series authors Annewieke van den Beld, Bu Yeap, Robin Peeters, and Zaki Hassan-Smith discuss how the endocrine system changes with age and the implications for healthy ageing. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal ht…

1
Ageing and endocrinology 25:32

6+ y ago25:32

25:32

Series authors Annewieke van den Beld, Bu Yeap, Robin Peeters, and Zaki Hassan-Smith discuss how the endocrine system changes with age and the implications for healthy ageing.Von The Lancet

1
Prediabetes in the USA 13:06

6+ y ago13:06

13:06

Mohammed Ali talks to The Lancet Diabetes & Endocrinology about the cardiovascular and renal burdens of prediabetes in the USA. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://yo…

1
Prediabetes in the USA 14:10

6+ y ago14:10

14:10

Mohammed Ali talks to The Lancet Diabetes & Endocrinology about the cardiovascular and renal burdens of prediabetes in the USA.Von The Lancet

1
Frequency of T1D: The Lancet Diabetes & Endocrinology: November 30, 2017 5:27

7y ago5:27

5:27

Richard Oram discusses a study which uses UK Biobank data to look at the frequency of type 1 diabetes across the first six decades of life. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lance…

1
Frequency of T1D: The Lancet Diabetes & Endocrinology: November 30, 2017 5:40

7y ago5:40

5:40

Richard Oram discusses a study which uses UK Biobank data to look at the frequency of type 1 diabetes across the first six decades of life.Von The Lancet

1
Iodine and child development: The Lancet Diabetes & Endocrinology: October 10, 2017 7:25

7y ago7:25

7:25

Michael Zimmerman talks about the effect of iodine supplementation in pregnant women on child development.Von The Lancet

1
Iodine and child development: The Lancet Diabetes & Endocrinology: October 10, 2017 6:33

7y ago6:33

6:33

Michael Zimmerman talks about the effect of iodine supplementation in pregnant women on child development. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv…

1
Diabetes in sub-Saharan Africa: The Lancet Diabetes & Endocrinology: July 5, 2017 6:54

7+ y ago6:54

6:54

Moffat Nyirenda talks about the challenges facing diabetes in sub-Saharan Africa, as highlighted in a new Commission.Von The Lancet

1
Diabetes in sub-Saharan Africa: The Lancet Diabetes & Endocrinology: July 5, 2017 6:33

7+ y ago6:33

6:33

Moffat Nyirenda talks about the challenges facing diabetes in sub-Saharan Africa, as highlighted in a new Commission. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/…

1
Outcomes after adrenalectomy: The Lancet Diabetes & Endocrinology: May 30, 2017 7:38

7+ y ago7:38

7:38

Martin Reincke discusses outcomes after adrenalectomy for unilateral primary aldosteronism. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv…

1
Outcomes after adrenalectomy: The Lancet Diabetes & Endocrinology: May 30, 2017 8:08

7+ y ago8:08

8:08

Martin Reincke discusses outcomes after adrenalectomy for unilateral primary aldosteronism.Von The Lancet

Podcasts, die es wert sind, gehört zu werden

The Lancet Diabetes Podcasts

Podcasts, die es wert sind, gehört zu werden

Kurzanleitung